Life Science Fund
The Life Science Fund plays a key part in nurturing the start-up ecosystem in life science fields, working with start-ups, pharmaceutical companies, and other entities to raise the standard of medical care both in Japan and worldwide, also contributing to the growth of the Japanese economy.
< Principal features >
- MUCAP-led deal making backed by the size of its funds, one of the largest in Japan.
- Total support by members of our specialized unit who are very familiar with these fields with regard to strategy, alliance building, and other tactics.
- Provision of know-how and expertise through its strong track record of cooperation with pharmaceutical companies and academia.
Drug Development Ecosystem
| Name | Mitsubishi UFJ Life Science IV, Limited Partnership |
|---|---|
| General partner | Mitsubishi UFJ Capital |
| Investors | MUFG Bank and Mitsubishi UFJ Capital |
| Total amount | 20 billion yen |
| Established | March 28 2023 |
| Fund term | 12 years |
| Name | MUFG Medical Fund (Registered name：Mitsubishi UFJ Life Science III, Limited Partnership) |
|---|---|
| General partner | Mitsubishi UFJ Capital |
| Investors | MUFG Bank and Mitsubishi UFJ Capital |
| Total amount | 10 billion yen |
| Established | June 22 2020 |
| Fund term | 12 years |
| Name | Mitsubishi UFJ Life Science II, Limited Partnership |
|---|---|
| General partner | Mitsubishi UFJ Capital |
| Investors | MUFG Bank and Mitsubishi UFJ Capital |
| Total amount | 10 billion yen |
| Established | February 20 2019 |
| Fund term | 12 years |
| Name | Mitsubishi UFJ Life Science I, Limited Partnership |
|---|---|
| General partner | Mitsubishi UFJ Capital |
| Investors | MUFG Bank and Mitsubishi UFJ Capital |
| Total amount | 10 billion yen |
| Established | February 20 2017 |
| Fund term | 12 years |